Lei Gao

3.8k total citations · 1 hit paper
170 papers, 2.4k citations indexed

About

Lei Gao is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Lei Gao has authored 170 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hematology, 56 papers in Oncology and 43 papers in Genetics. Recurrent topics in Lei Gao's work include Hematopoietic Stem Cell Transplantation (53 papers), Acute Myeloid Leukemia Research (34 papers) and CAR-T cell therapy research (26 papers). Lei Gao is often cited by papers focused on Hematopoietic Stem Cell Transplantation (53 papers), Acute Myeloid Leukemia Research (34 papers) and CAR-T cell therapy research (26 papers). Lei Gao collaborates with scholars based in China, United States and Netherlands. Lei Gao's co-authors include Xi Zhang, Li Gao, Shi‐Cang Yu, Yao Liu, Peiyan Kong, Xiu‐Wu Bian, Cheng Zhang, Ruihao Huang, Jiang F. Zhong and Xiangui Peng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lei Gao

157 papers receiving 2.4k citations

Hit Papers

Recent advances in CAR-T ... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Gao China 25 986 711 667 562 467 170 2.4k
Ting Niu China 27 800 0.8× 1.3k 1.8× 963 1.4× 607 1.1× 344 0.7× 230 3.0k
Lan Coffman United States 21 811 0.8× 844 1.2× 848 1.3× 449 0.8× 592 1.3× 48 2.8k
Concetta Conticello Italy 24 1.7k 1.7× 1.4k 2.0× 649 1.0× 506 0.9× 326 0.7× 91 3.0k
Olivier Hérault France 24 534 0.5× 1.0k 1.4× 704 1.1× 418 0.7× 979 2.1× 99 2.8k
Akos Czibere United States 29 1.2k 1.2× 1.0k 1.4× 804 1.2× 326 0.6× 273 0.6× 112 2.6k
Michael Steurer Austria 27 745 0.8× 885 1.2× 615 0.9× 799 1.4× 663 1.4× 103 2.7k
Lugui Qiu China 27 1.3k 1.3× 1.5k 2.1× 1.4k 2.1× 494 0.9× 503 1.1× 255 2.9k
Nils von Neuhoff Germany 28 465 0.5× 1.2k 1.7× 1.0k 1.5× 421 0.7× 686 1.5× 99 2.9k
Akil Merchant United States 24 836 0.8× 1.5k 2.0× 818 1.2× 333 0.6× 226 0.5× 84 2.5k
Ying Huang China 25 1.1k 1.1× 478 0.7× 363 0.5× 323 0.6× 591 1.3× 203 2.2k

Countries citing papers authored by Lei Gao

Since Specialization
Citations

This map shows the geographic impact of Lei Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Gao more than expected).

Fields of papers citing papers by Lei Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Gao. The network helps show where Lei Gao may publish in the future.

Co-authorship network of co-authors of Lei Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Gao. A scholar is included among the top collaborators of Lei Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Gao. Lei Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoqi, Xu Tan, Yingying Ma, et al.. (2025). Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial. Experimental Hematology and Oncology. 14(1). 1–1. 17 indexed citations
2.
Li, Xin, Xu Zhang, Jin Sun, et al.. (2024). Inhibition of Neospora caninum activity by niclosamide: Evidence from in vitro and in vivo studies. Veterinary Parasitology. 334. 110362–110362.
3.
Wang, Libing, Tao Wang, Mingyu Ye, et al.. (2024). Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults. Cancer Medicine. 13(10). e7310–e7310. 1 indexed citations
4.
Song, Zhiqiang, Yang Wang, Dongliang Zhang, et al.. (2024). Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS. International Journal of Cancer. 156(5). 1033–1042.
5.
Xiao, Tong, et al.. (2024). Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia. Therapeutic Advances in Hematology. 15. 1574201037–1574201037. 4 indexed citations
7.
Gao, Lei, Bofang Wang, Yang Yu, et al.. (2024). FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription. Journal for ImmunoTherapy of Cancer. 12(7). e009565–e009565. 6 indexed citations
8.
Wang, Dan, Hanqing Zeng, Zhongmin Zou, et al.. (2023). Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantation. Transplant Immunology. 81. 101948–101948. 1 indexed citations
9.
Zhang, Cheng, Xu Tan, Jieping Li, et al.. (2023). Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia. Cancer Medicine. 12(11). 12377–12387. 4 indexed citations
11.
Li, Jiali, Jun Rao, Lei Gao, et al.. (2023). Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia. PPAR Research. 2023. 1–11.
12.
Yu, Yang, Lei Gao, Xiang Lin, et al.. (2023). Predictive Roles of ADAM17 in Patient Survival and Immune Cell Infiltration in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(23). 17069–17069. 2 indexed citations
13.
Zhu, Lidan, Jia Liu, Peiyan Kong, et al.. (2022). Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 13. 910893–910893. 8 indexed citations
14.
Liu, Zhiqiang, Weiwei Hu, Hanwen Zhang, et al.. (2022). EAT Thickness as a Predominant Feature for Evaluating Arterial Stiffness in Patients with Heart Failure with Preserved Ejection Fraction. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1217–1226. 11 indexed citations
15.
Chen, Min, Nan Hong, Shan Hu, et al.. (2020). Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: A case study. Journal of Infection. 81(4). 634–638. 9 indexed citations
16.
Zhang, Hua, Lei Gao, Li Liu, et al.. (2019). A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3147–3147. 43 indexed citations
17.
Wang, Sanbin, Jishi Wang, Li Liu, et al.. (2018). Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China. Scientific Reports. 8(1). 2479–2479. 18 indexed citations
18.
Zhang, Xi, Cheng Zhang, Lei Gao, et al.. (2011). Human Umbilical Cord Blood-Derived Stromal Cells Are Superior to Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Inducing Myeloid Lineage Differentiation In Vitro. Stem Cells and Development. 21(9). 1429–1440. 10 indexed citations
19.
Hao, Lei, Lei Gao, Zhongmin Zou, et al.. (2010). Human umbilical cord blood-derived stromal cells prevent graft-versus-host disease in mice following haplo-identical stem cell transplantation. Cytotherapy. 13(1). 83–91. 17 indexed citations
20.
Yu, Shi‐Cang, Yi‐Fang Ping, Yi Liang, et al.. (2008). Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Letters. 265(1). 124–134. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026